Legislative Activity FDA User Fee Reauthorization Moves to Full Committee While passing health reform through Congress has been a struggle, the Food and Drug Administration (FDA) user fee legislation has quickly moved through the regular order process in a bipartisan fashion. S. 934/H.R. 2430, Food and Drug Administration Reauthorization Act of 2017 (FDARA), renews FDA’s … Continue Reading
Legislative Activity Next Stop: The Senate After an uphill battle and much compromise, H.R. 1628, the American Health Care Act (AHCA), passed the House of Representatives on Thursday, May 4, by a vote of 217 ayes to 213 nays. At the beginning of the week a favorable outcome for the AHCA seemed unlikely. Speaker Ryan … Continue Reading
